www.fdanews.com/articles/177214-polyganics-secures-ce-mark-for-neurocap
![](https://www.fdanews.com/ext/resources/test/Device_Images5/Brain_SideView.gif?t=1474538952&width=430)
Polyganics Secures CE Mark for NEUROCAP
June 22, 2016
Netherlands-based Polyganics has received CE marking for Neurocap to treat and reduce neuroma formation.
The nerve capping device is an absorbable implant designed to shield a peripheral nerve end to avoid the development of symptomatic end-neuroma.
The company plans on launching the product, which was cleared last January, in some EU countries later this year. — Anisa Jibrell